Elevance Health Overview
Elevance Health Target Price
Analysts' 12-month price predictions for ELV.
Get informed when a big investor buys or sells
+ FollowShare Price
$391.27
Average Target Price
$411.60
5.2% upside
5.2% upside10 analysts in the last 4 months
High: $498 | Low: $331
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-26 | BarclaysAndrew Mok | $480 | 22.7% upside |  |
| 2026-05-22 | UBS | $460 | 17.6% upside | |
| 2026-05-20 | Mizuho Securities | $435 | 11.2% upside | |
| 2026-05-20 | Deutsche Bank | $498 | 27.3% upside | |
| 2026-04-24 | Guggenheim | $399 | 2% upside | |
| 2026-04-24 | Barclays | $408 | 4.3% upside | |
| 2026-04-23 | Leerink Partners | $364 |  7% downside | |
| 2026-04-23 | Robert W. Baird | $331 | 15.4% downside | |
| 2026-04-20 | JefferiesDavid Windley | $391 | 0.1% downside | |
| 2026-03-10 | Mizuho SecuritiesAnn Hynes | $350 | 10.5% downside | |
| 2026-02-03 | RBC Capital | $358 | 8.5% downside | |
| 2026-02-02 | Truist Financial | $390 | 0.3% downside | |
| 2026-02-02 | Piper Sandler | $409 | 4.5% upside | |
| 2026-02-02 | Craig-Hallum | $409 | 4.5% upside | |
| 2026-02-01 | Bernstein | $409 | 4.5% upside | |
| 2026-01-30 | Wells Fargo | $391 | 0.1% downside | |
| 2026-01-30 | Barclays | $393 | 0.4% upside | |
| 2026-01-29 | UBS | $400 | 2.2% upside | |
| 2026-01-29 | Deutsche Bank | $332 | 15.1% downside | |
| 2026-01-29 | GuggenheimJason Cassorla | $396 | 1.2% upside | |
| 2026-01-22 | GuggenheimJason Cassorla | $414 | 5.8% upside | |
| 2026-01-09 | Mizuho SecuritiesAnn Hynes | $413 | 5.6% upside | |
| 2026-01-08 | Wolfe ResearchJustin Lake | $425 | 8.6% upside | |
| 2026-01-07 | Wells Fargo | $424 | 8.4% upside | |
| 2026-01-06 | Bernstein | $431 | 10.2% upside | |
| 2026-01-05 | BarclaysAndrew Mok | $404 | 3.3% upside | |
| 2025-12-19 | Deutsche BankGeorge Hill | $320 | 18.2% downside | |
| 2025-12-18 | Morgan Stanley | $352 | 10% downside | |
| 2025-11-03 | Mizuho Securities | $400 | 2.2% upside | |
| 2025-10-22 | Barclays | $385 | 1.6% downside | |
| 2025-10-21 | Bernstein | $420 | 7.3% upside | |
| 2025-10-14 | Truist Financial | $400 | 2.2% upside | |
| 2025-10-14 | Morgan StanleyErin Wright | $359 | 8.2% downside | |
| 2025-10-14 | Goldman Sachs | $343 | 12.3% downside | |
| 2025-10-09 | Mizuho Securities | $420 | 7.3% upside | |
| 2025-10-09 | Barclays | $395 | 1% upside | |
| 2025-10-08 | Guggenheim | $398 | 1.7% upside | |
| 2025-10-07 | Wells FargoStephen Baxter | $412 | 5.3% upside | |
| 2025-06-09 | Truist FinancialDavid MacDonald | $500 | 27.8% upside | |
| 2025-04-25 | Argus Research | $465 | 18.8% upside | |
| 2024-10-21 | JefferiesDavid Windley | $529 | 35.2% upside | |
| 2024-10-21 | Leerink PartnersWhit Mayo | $515 | 31.6% upside | |
| 2024-10-18 | Raymond JamesSarah James | $485 | 24% upside | |
| 2024-10-18 | RBC CapitalBen Hendrix | $478 | 22.2% upside | |
| 2024-10-18 | Truist FinancialDavid MacDonald | $520 | 32.9% upside | |
| 2024-10-16 | Robert W. BairdMichael Ha | $625 | 59.7% upside | |
| 2024-07-18 | RBC CapitalBen Hendrix | $585 | 49.5% upside | |
| 2024-07-15 | Truist FinancialDavid MacDonald | $620 | 58.5% upside | |
| 2024-06-24 | Morgan StanleyErin Wright | $643 | 64.3% upside | |
| 2024-05-29 | Robert W. BairdMichael Ha | $649 | 65.9% upside | |